Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Am J Ophthalmol

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MCLEAN IW, Foster WD, Zimmerman LE, Gamel JW, et al
    Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology.
    Am J Ophthalmol. 2018;195:lvi-lx.
    PubMed     Text format     Abstract available


    August 2018
  2. CAI L, Paez-Escamilla M, Walter SD, Tarlan B, et al
    Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
    Am J Ophthalmol. 2018 Aug 6. pii: S0002-9394(18)30438.
    PubMed     Text format     Abstract available


  3. DEMIRCI H, Niziol LM, Ozkurt Z, Slimani N, et al
    Do Largest Basal Tumor Diameter and the American Joint Commission Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma?
    Am J Ophthalmol. 2018 Aug 3. pii: S0002-9394(18)30426.
    PubMed     Text format     Abstract available


    April 2018
  4. SEIBEL I, Riechardt AI, Erb-Eigner K, Boker A, et al
    Proton beam irradiation: a safe procedure in post-equatorial extraocular extension from uveal melanoma.
    Am J Ophthalmol. 2018 Apr 12. pii: S0002-9394(18)30166.
    PubMed     Text format     Abstract available


    March 2018
  5. DAMATO B, Hope-Stone L, Cooper B, Brown S, et al
    Patient-Reported Outcomes and Quality of Life after Treatment of Choroidal Melanoma: a Comparison of Enucleation vs Radiotherapy in 1596 patients.
    Am J Ophthalmol. 2018 Mar 16. pii: S0002-9394(18)30113.
    PubMed     Text format     Abstract available


  6. GLASGOW BJ, McCannel TA
    Correlation of immunocytochemistry of BRCA1-associated protein 1 (BAP1) with other prognostic markers in uveal melanoma.
    Am J Ophthalmol. 2018 Mar 9. pii: S0002-9394(18)30103.
    PubMed     Text format     Abstract available


    January 2018
  7. MAHESHWARI A, Finger PT
    A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve.
    Am J Ophthalmol. 2018 Jan 31. pii: S0002-9394(18)30032.
    PubMed     Text format     Abstract available


    November 2017
  8. OELLERS P, Mowery YM, Perez BA, Stinnett S, et al
    Efficacy and safety of low dose iodine plaque brachytherapy for juxtapapillary choroidal melanoma.
    Am J Ophthalmol. 2017 Nov 30. pii: S0002-9394(17)30486.
    PubMed     Text format     Abstract available


    July 2017
  9. FINGER PT, Sauerwein WAG
    Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Am J Ophthalmol. 2017 Jul 27. pii: S0002-9394(17)30283.
    PubMed     Text format    


  10. BELLERIVE C, Aziz HA, Bena J, Wilkinson A, et al
    Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Am J Ophthalmol. 2017 Jul 26. pii: S0002-9394(17)30284.
    PubMed     Text format    


    June 2017
  11. FABIAN ID, Thaung C, AlHarby L, Sisley K, et al
    Late Solitary Extraocular Recurrence from Previously Resected Iris Melanoma.
    Am J Ophthalmol. 2017 Jun 30. pii: S0002-9394(17)30279.
    PubMed     Text format     Abstract available


  12. SELLAM A, Coscas F, Lumbroso-Le Rouic L, Dendale R, et al
    Optical Coherence Tomography-Angiography of Macular Features after Proton Beam Radiotherapy for Small Choroidal Melanoma.
    Am J Ophthalmol. 2017 Jun 21. pii: S0002-9394(17)30251.
    PubMed     Text format     Abstract available


  13. SEIBEL I, Riechardt AI, Heufelder J, Cordini D, et al
    Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Am J Ophthalmol. 2017;178:94-100.
    PubMed     Text format     Abstract available


    May 2017
  14. SANCHEZ-TABERNERO S, Garcia-Alvarez C, Munoz-Moreno MF, Diezhandino P, et al
    Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Am J Ophthalmol. 2017 May 29. pii: S0002-9394(17)30221.
    PubMed     Text format     Abstract available


    February 2017
  15. BELLERIVE C, Aziz HA, Bena J, Wilkinson A, et al
    Local Failure after Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors and Management.
    Am J Ophthalmol. 2017 Feb 2. pii: S0002-9394(17)30048.
    PubMed     Text format     Abstract available


  16. ARES WJ, Tonetti D, Yu JY, Monaco EA, et al
    Gamma Knife Radiosurgery for Uveal Metastases: Report of Three Cases and a Review of the Literature.
    Am J Ophthalmol. 2017;174:169-174.
    PubMed     Text format     Abstract available


    December 2016
  17. KING B, Morales-Tirado VM, Wynn HG, Gao BT, et al
    Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    Am J Ophthalmol. 2016 Dec 31. pii: S0002-9394(16)30629.
    PubMed     Text format     Abstract available


  18. SNYDER ME, Osher RH, Wladecki TM, Perez MA, et al
    Results in combined cataract surgery with prosthetic iris implantation in patients with previous iridocyclectomy for iris melanoma.
    Am J Ophthalmol. 2016 Dec 6. pii: S0002-9394(16)30588.
    PubMed     Text format     Abstract available


    November 2016
  19. KIM RS, Chevez-Barrios P, Bretana ME, Wong TP, et al
    Histopathologic Analysis of Trans-vitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma.
    Am J Ophthalmol. 2016 Nov 3. pii: S0002-9394(16)30532.
    PubMed     Text format     Abstract available


    June 2016
  20. IOVIENO A, Longo C, De Luca M, Piana S, et al
    Fluorescence confocal microscopy for ex vivo diagnosis of conjunctival tumors: a pilot study.
    Am J Ophthalmol. 2016 Jun 10. pii: S0002-9394(16)30265.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: